Advertisement

Topics

JPT Peptide Technologies GmbH Company Profile

09:47 EDT 20th June 2018 | BioPortfolio

NIL

Location

Volmerstrasse 5 (UTZ)
Berlin
12489
Germany

Contact

Phone: 49-30-6392-7878
Fax: 49-30-6392-7888
Email: peptide@jpt.com


News Articles [655 Associated News Articles listed on BioPortfolio]

JPT Peptide Technologies Launches The Human Proteome Peptide Catalog

JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most comprehensive online resource for validated reference peptides in mas...

This Oxford Biotech is Using mRNA to Find New Peptide Drugs

Today, we’re in Oxford, UK, visiting Orbit Discovery. The biotech develops peptide drugs for chronic diseases using mRNA display technologies by linking proteins to their encoding DNA. Mission:...

Breakthrough for Peptide Medication: New Strategy Makes Peptide Active Agents Available Orally

Breakthrough for peptide medication - The “Holy Grail” of peptide chemistry: Making peptide active agents available orally. Peptides, short amino acid chains that control many functions in...

Researchers may have found a way to administer peptide therapies orally

Research from a team led by the Technical University of Munich (TUM) has uncovered a breakthrough in peptide chemistry that may enable the administration of peptide active agents orally.

United Technologies Corporation: Aus Carrier und CIAT wird UTC Klimatechnik GmbH

Innerhalb der UTC Klimatechnik GmbH werden die beiden Marken als getrennte Geschäftsbereiche geführt. Die Vertriebsleitung für CIAT hat zum Jahresanfang Reinhard Kern übernommen. Der Kälteanlagen...

Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA

CRANBURY, N.J., June 4, 2018 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment ...

Biologists’ new peptide could fight many cancers

MIT biologists have designed a new peptide that can disrupt a key

Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors

A collaboration between Bicycle Therapeutics and Cancer Research UK has yielded its first peptide to enter clinical trials for solid tumors. Bicycle Therapeutics, the pioneer of the bicyclic peptide p...

PubMed Articles [1269 Associated PubMed Articles listed on BioPortfolio]

Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.

DNA methylation, one of the most studied epigenetic modifications, regulates many biological processes. Dysregulation of DNA methylation is implicated in the etiology of several diseases, such as canc...

Novel peptide inhibits inflammation by suppressing of protease activated receptor-2.

We synthesized and investigated the effects of a novel peptide B, RRFSLLRY as a novel PAR-2 antagonist. Peptide B decreased calcium levels in HaCat cells stimulated with trypsin and PAR-2 activator (S...

Delivery of a Pro-apoptotic Peptide to EGFR-positive Cancer Cells by a Cyclic Peptide Mimicking the Dimerization Arm Structure of EGFR.

A cyclic decapeptide, CQTPYYMNTC (1), which mimics the dimerization arm of the EGF receptor (EGFR), was previously found to be captured into cells. We have sought to investigate the promising potentia...

Zein nanoparticle as a novel BMP6 derived peptide carrier for enhanced osteogenic differentiation of C2C12 cells.

Zein nanoparticles as a carrier system for BMP6-derived peptide were prepared by liquid-liquid phase separation procedure and characterized with SEM, DLS, FTIR and thermogravimetric methods. After pep...

New trends in aggregating tags for therapeutic protein purification.

The rapid growth of the therapeutic protein market calls for more efficient purification methods. Various aggregating tags have recently emerged as simple, fast, cost-effective and column-free technol...

Clinical Trials [1147 Associated Clinical Trials listed on BioPortfolio]

Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

Immunotherapy is now considered to be one of promising approaches for treating cancer. Radiation therapy has been to be a cornerstone treatment for unresectable advanced esophageal cancer....

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

To evaluate the chemical efficacy and safety of intranasally administered peptide T on neurocognitive function in HIV seropositive individuals. Previous studies have shown that treatment ...

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

To evaluate safety and immunogenicity of 2 different HIV-1 peptide candidate vaccines, the UBI HIV-1 MN PND peptide immunogen and the UBI microparticulate monovalent HIV-1 MN branched pept...

Patient-individualized Peptide Vaccination in Combination With Lenalidomide After First Line Therapy of CLL

The aim of this study is to induce a peptide-specific immune response in chronic lymphatic leukaemia (CLL) patients by multi-peptide vaccination with a patient-individualized peptide cockt...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Companies [1974 Associated Companies listed on BioPortfolio]

JPT Peptide Technologies GmbH

NIL

Peptide Resource Page

Welcome to the Peptide Resource Page (PRP). Founded in 2004, the PRP is designed to help researchers and educators navigate through the maze of peptide related websites. Search our pages to find pepti...

Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide rece...

AFFiRiS GmbH

AFFiRiS GmbH develops peptide-based vaccines for the treatment of Alzheimer's disease, atherosclerosis and other diseases that urgently require a medical solution. The company has established plat...

Peptide Solutions

Peptide Solutions LLC is a distribution partner for Iris Biotech GmbH in North America and is recognized as a leading supplier of reagents used in drug discovery, drug delivery an...

More Information about "JPT Peptide Technologies GmbH" on BioPortfolio

We have published hundreds of JPT Peptide Technologies GmbH news stories on BioPortfolio along with dozens of JPT Peptide Technologies GmbH Clinical Trials and PubMed Articles about JPT Peptide Technologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of JPT Peptide Technologies GmbH Companies in our database. You can also find out about relevant JPT Peptide Technologies GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record